Literature DB >> 35435606

FLORA software: semi-automatic LGE-CMR analysis tool for cardiac lesions identification and characterization.

Silvia Pradella1,2, Lorenzo Nicola Mazzoni3,4, Mayla Letteriello1, Paolo Tortoli4, Silvia Bettarini4, Cristian De Amicis1, Giulia Grazzini5, Simone Busoni4, Pierpaolo Palumbo2,6, Giacomo Belli4, Vittorio Miele1.   

Abstract

PURPOSE: Today there is a growing interest in the quantification of late gadolinium enhancement (LGE) in ischemic and non-ischemic cardiac pathologies. We build an automatic self-made free software FLORA (For Late gadOlinium enhanced aReas clAssification) for the recognition, classification and quantification of LGE areas that allows to improve the observer's performances and that homogenizes the evaluations between different operators.
MATERIAL AND METHODS: We have retrospectively selected 120 CMR exams: 40-ischemic with evident scar tissue on LGE sequences; 40-non-ischemic cardiomyopathy; 40-any myocardial alteration on CMR, especially on LGE sequences. FLORA's performance was compared to the radiologist's evaluation.
RESULTS: FLORA identified both ischemic and non-ischemic myocardial lesions in almost all cases (80/80 and 79/80 for the double-Gaussian fit method and fixed-shift method, respectively, with sensitivity and specificity of 100%/98.8% and 55%/50%, respectively). The best results were obtained from the classification of ischemic myocardial damage, which was correctly identified in 85%-95% of cases. FLORA also increases the agreement between observers and allows a quantitative evaluation of transmurality.
CONCLUSIONS: FLORA has proven to be an applicable tool that improves and facilitates the classification of LGE areas allowing their quantification.
© 2022. Italian Society of Medical Radiology.

Entities:  

Keywords:  Cardiac radiology; Ischemic cardiomyopathies; Late gadolinium enhancement (LGE); Magnetic resonance imaging (MRI); Non-ischemic cardiomyopathies; Quantification software

Mesh:

Substances:

Year:  2022        PMID: 35435606     DOI: 10.1007/s11547-022-01491-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  61 in total

1.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

Authors:  Ravi G Assomull; Sanjay K Prasad; Jonathan Lyne; Gillian Smith; Elizabeth D Burman; Mohammed Khan; Mary N Sheppard; Philip A Poole-Wilson; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

Review 2.  Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies.

Authors:  Silvia Pradella; Giulia Grazzini; Cristian De Amicis; Mayla Letteriello; Manlio Acquafresca; Vittorio Miele
Journal:  Radiol Med       Date:  2020-09-18       Impact factor: 3.469

Review 3.  The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.

Authors:  Marthe A J Becker; Jan H Cornel; Peter M van de Ven; Albert C van Rossum; Cornelis P Allaart; Tjeerd Germans
Journal:  JACC Cardiovasc Imaging       Date:  2018-04-18

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

Review 6.  Practical Guide to Evaluating Myocardial Disease by Cardiac MRI.

Authors:  Elizabeth Lee; El-Sayed H Ibrahim; Purvi Parwani; Nicole Bhave; Jadranka Stojanovska
Journal:  AJR Am J Roentgenol       Date:  2020-01-22       Impact factor: 3.959

Review 7.  Role of cardiac MRI in nonischemic cardiomyopathies.

Authors:  Senthil Anand; Rajesh Janardhanan
Journal:  Indian Heart J       Date:  2016-01-18

8.  Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.

Authors:  Christoph Gräni; Christian Eichhorn; Loïc Bière; Kyoichi Kaneko; Venkatesh L Murthy; Vikram Agarwal; Ayaz Aghayev; Michael Steigner; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  J Cardiovasc Magn Reson       Date:  2019-02-28       Impact factor: 5.364

9.  Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.

Authors:  Robert J Holtackers; Caroline M Van De Heyning; Muhummad Sohaib Nazir; Imran Rashid; Ioannis Ntalas; Haseeb Rahman; René M Botnar; Amedeo Chiribiri
Journal:  J Cardiovasc Magn Reson       Date:  2019-07-29       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.